2020 澳大利亚建议:肝细胞癌的管理

2020-12-13 国外肿瘤科相关专家小组(统称) Med J Aust . 2020 Dec 13.

本文主要针对肝细胞癌的管理提供指导建议,设计4个主要领域,分别为肝细胞癌的流行病学和发病率,诊断,治疗和患者管理。

中文标题:

2020 澳大利亚建议:肝细胞癌的管理

英文标题:

Australian recommendations for the management of hepatocellular carcinoma: a consensus statement

发布日期:

2020-12-13

简要介绍:

本文主要针对肝细胞癌的管理提供指导建议,设计4个主要领域,分别为肝细胞癌的流行病学和发病率,诊断,治疗和患者管理。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 澳大利亚建议:肝细胞癌的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=998331c00203a38a, title=2020 澳大利亚建议:肝细胞癌的管理, enTitle=Australian recommendations for the management of hepatocellular carcinoma: a consensus statement, guiderFrom=Med J Aust . 2020 Dec 13., authorId=0, author=, summary=本文主要针对肝细胞癌的管理提供指导建议,设计4个主要领域,分别为肝细胞癌的流行病学和发病率,诊断,治疗和患者管理。, cover=https://img.medsci.cn/20201231/1609346279023_2020535.jpg, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Sun Dec 13 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>本文主要针对肝细胞癌的管理提供指导建议,设计4个主要领域,分别为肝细胞癌的流行病学和发病率,诊断,治疗和患者管理。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=357, tagName=肝细胞癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=357, guiderKeyword=肝细胞癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=9, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8793, appHits=111, showAppHits=0, pcHits=419, showPcHits=8682, likes=2, shares=31, comments=6, approvalStatus=1, publishedTime=Thu Dec 31 01:13:23 CST 2020, publishedTimeString=2020-12-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Dec 31 00:38:06 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 01:28:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 澳大利亚建议:肝细胞癌的管理.pdf)])
2020 澳大利亚建议:肝细胞癌的管理.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=912728, encodeId=d3fa912e28c9, content= Australian recommendations for the management of hepatocellular carcinoma: a consensus statement, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Dec 31 20:39:43 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917294, encodeId=298c91e29437, content=没有中文吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=896b5453417, createdName=ms6000001910474587, createdTime=Sun Jan 17 00:56:46 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913856, encodeId=dd1d913856fa, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423e5450162, createdName=心儿, createdTime=Tue Jan 05 12:00:20 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913661, encodeId=2dd2913661c0, content=很有用! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/a574549869e3a40dd94143c051d4ee5f.jpg, createdBy=d8974694275, createdName=老医生, createdTime=Mon Jan 04 18:57:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913522, encodeId=0ca5913522cd, content=中国指南?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:30:35 CST 2021, time=2021-01-04, status=1, ipAttribution=)]
    2020-12-31 oo902

    Australian recommendations for the management of hepatocellular carcinoma: a consensus statement

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=912728, encodeId=d3fa912e28c9, content= Australian recommendations for the management of hepatocellular carcinoma: a consensus statement, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Dec 31 20:39:43 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917294, encodeId=298c91e29437, content=没有中文吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=896b5453417, createdName=ms6000001910474587, createdTime=Sun Jan 17 00:56:46 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913856, encodeId=dd1d913856fa, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423e5450162, createdName=心儿, createdTime=Tue Jan 05 12:00:20 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913661, encodeId=2dd2913661c0, content=很有用! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/a574549869e3a40dd94143c051d4ee5f.jpg, createdBy=d8974694275, createdName=老医生, createdTime=Mon Jan 04 18:57:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913522, encodeId=0ca5913522cd, content=中国指南?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:30:35 CST 2021, time=2021-01-04, status=1, ipAttribution=)]
    2021-01-17 ms6000001910474587

    没有中文吗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=912728, encodeId=d3fa912e28c9, content= Australian recommendations for the management of hepatocellular carcinoma: a consensus statement, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Dec 31 20:39:43 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917294, encodeId=298c91e29437, content=没有中文吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=896b5453417, createdName=ms6000001910474587, createdTime=Sun Jan 17 00:56:46 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913856, encodeId=dd1d913856fa, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423e5450162, createdName=心儿, createdTime=Tue Jan 05 12:00:20 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913661, encodeId=2dd2913661c0, content=很有用! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/a574549869e3a40dd94143c051d4ee5f.jpg, createdBy=d8974694275, createdName=老医生, createdTime=Mon Jan 04 18:57:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913522, encodeId=0ca5913522cd, content=中国指南?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:30:35 CST 2021, time=2021-01-04, status=1, ipAttribution=)]
    2021-01-05 心儿

    很有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=912728, encodeId=d3fa912e28c9, content= Australian recommendations for the management of hepatocellular carcinoma: a consensus statement, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Dec 31 20:39:43 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917294, encodeId=298c91e29437, content=没有中文吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=896b5453417, createdName=ms6000001910474587, createdTime=Sun Jan 17 00:56:46 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913856, encodeId=dd1d913856fa, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423e5450162, createdName=心儿, createdTime=Tue Jan 05 12:00:20 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913661, encodeId=2dd2913661c0, content=很有用! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/a574549869e3a40dd94143c051d4ee5f.jpg, createdBy=d8974694275, createdName=老医生, createdTime=Mon Jan 04 18:57:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913522, encodeId=0ca5913522cd, content=中国指南?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:30:35 CST 2021, time=2021-01-04, status=1, ipAttribution=)]
    2021-01-04 老医生

    很有用!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=912728, encodeId=d3fa912e28c9, content= Australian recommendations for the management of hepatocellular carcinoma: a consensus statement, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Dec 31 20:39:43 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917294, encodeId=298c91e29437, content=没有中文吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=896b5453417, createdName=ms6000001910474587, createdTime=Sun Jan 17 00:56:46 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913856, encodeId=dd1d913856fa, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423e5450162, createdName=心儿, createdTime=Tue Jan 05 12:00:20 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913661, encodeId=2dd2913661c0, content=很有用! , beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/a574549869e3a40dd94143c051d4ee5f.jpg, createdBy=d8974694275, createdName=老医生, createdTime=Mon Jan 04 18:57:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913522, encodeId=0ca5913522cd, content=中国指南?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:30:35 CST 2021, time=2021-01-04, status=1, ipAttribution=)]
    2021-01-04 dajunma

    中国指南?

    0

拓展阅读

2013 JSH循证临床实践指南:肝细胞癌-更新版(JSH-HCC指南第3版)

日本肝脏学会(JSH,The Japan Society of Hepatology) · 2015-01-20

肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2016年版)

全国肝癌合并癌栓诊治研究协作组 · 2016-06-02

肝脏影像报告和数据系统管理工作组肝细胞癌诊断共识意见

美国肝病研究学会(AASLD,American Association for the Study of Liver Diseases) · 2016-06-02

肝细胞癌合并血管侵犯专家共识(讨论稿)

中国医疗保健国际交流促进会 · 2016-06-02

2014年KLCSG-NCC实践指南:肝细胞癌

暂未更新 · 2016-06-03